Application of truncated immunodominant polypeptide from hepatitis E virus (HEV) ORF2 in an assay to exclude nonspecific binding in detecting anti-HEV immunoglobulin M

Journal of Clinical Microbiology

Volumn 48, Issue 3, 2010, Pages 779-784

  Pan, Jin Shun ^a,c   Zhang, Kui ^a   Zhou, Jinyong ^a,c   Wu, Chao ^a   Zhuang, Hui ^b   Zhou, Yi Hua ^a,c  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANYLALANYLTYROSYLGLYCYLCYSTEINYLTHREONYLCYSTEINYLALANYLGLYCYLCYSTEINYLALANYLGLYCYLGLYCYLALANYLTYROSYLALANYLALANYLGLYCYLGLYCYLGLYCINE; CYSTEINYLALANYLTYROSYLTHREONYLCYSTEINYLHISTIDYLGLYCYLGLYCYLGLYCYLCYSTEINYLALANYLARGINYLALANYLALANYLARGINYLTHREONYLCYSTEINYLALANYLTHREONYLCYSTEINE; CYSTEINYLCYSTEINYLGLYCYLALANYLCYSTEINYLALANYLGLYCYLALANYLALANYLTHREONYLTHREONYLGLYCYLALANYLTHREONYLTHREONYLTHREONYLCYSTEINYLGLYCYLTHREONYLCYSTEINE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; POLYPEPTIDE; RECOMBINANT PROTEIN; THREONYLTHREONYLALANYLCYSTEINYLCYSTEINYLTYROSYLALANYLCYSTEINYLCYSTEINYLTHREONYLTHREONYLCYSTEINYLALANYLTHREONYLTYROSYLTHREONYLTHREONYLALANYLALANYLGLYCINE; UNCLASSIFIED DRUG; VIRUS RNA;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC KIT; DIMERIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENELABS KIT; GENOTYPE; HEPATITIS E VIRUS; HUMAN; HUMAN EXPERIMENT; IMMUNOASSAY; MOLECULAR CLONING; NONHUMAN; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; OPTICAL DENSITY; PRIORITY JOURNAL; SEROLOGY; SEROPREVALENCE; VIRAL GENETICS; VIRUS DETECTION; VIRUS GENE; WESTERN BLOTTING;

ANTIGENS, VIRAL; CLINICAL LABORATORY TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOGLOBULIN M; SENSITIVITY AND SPECIFICITY; VIRAL PROTEINS;

HEPATITIS E VIRUS;

EID: 77749340356     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01671-09     Document Type: Article

References (30)

1. Aggarwal, R., and S. Jameel. 2008. Hepatitis E vaccine. Hepatol. Int. 2:308-315.
2. Aggarwal, R., and S. Naik. 2009. Epidemiology of hepatitis E: current status. J. Gastroenterol. Hepatol. 24:1484-1493. doi:10.1111/j.14401746.2009.05933.x.
3. Atiq, M., N. J. Shire, A. Barrett, S. D. Rouster, K. E. Sherman, and M. T. Shata. 2009. Hepatitis E virus antibodies in patients with chronic liver disease. Emerg. Infect. Dis. 15:479-481.
4. Bendall, R., V. Ellis, S. Ijaz, P. Thurairajah, and H. R. Dalton. 2008. Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response. J. Med. Virol. 80:95-101.
5. Chen, H. Y., Y. Lu, T. Howard, D. Anderson, P. Y. Fong, W. P. Hu, C. P. Chia, and M. Guan. 2005. Comparison of a new immunochromatographic test to enzyme-linked immunosorbent assay for rapid detection of immunoglobulin M antibodies to hepatitis E virus in human sera. Clin. Diagn. Lab. Immunol. 12:593-598.
6. Dawson, G. J., K. H. Chau, C. M. Cabal, P. O. Yarbough, G. R. Reyes, and I. K. Mushahwar. 1992. Solid-phase enzyme-linked immunosorbent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides. J. Virol. Methods 38:175-186.
7. Dong, C., X. Dai, J. S. Shao, K. Hu, and J. H. Meng. 2007. Identification of genetic diversity of hepatitis E virus (HEV) and determination of the seroprevalence of HEV in eastern China. Arch. Virol. 152:739-746.
8. Elkady, A., Y. Tanaka, F. Kurbanov, N. Hirashima, M. Sugiyama, A. Khan, H. Kato, A. Okumura, and M. Mizokami. 2007. Evaluation of anti-hepatitis E virus (HEV) immunoglobulin A in a serological screening for HEV infection. J. Gastroenterol. 42:911-917.
9. Fogeda, M., F. de Ory, A. Avellon, and J. M. Echevarria. 2009. Differential diagnosis of hepatitis E virus, cytomegalovirus and Epstein-Barr virus infection in patients with suspected hepatitis E. J. Clin. Virol. 45:259-261.
10. Guu, T. S., Z. Liu, Q. Ye, D. A. Mata, K. Li, C. Yin, J. Zhang, and Y. J. Tao. 2009. Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding. Proc. Natl. Acad. Sci. USA 106:12992-12997.
11. Jameel, S., M. Zafrullah, M. H. Ozdener, and S. K. Panda. 1996. Expression in animal cells and characterization of the hepatitis E virus structural proteins. J. Virol. 70:207-216.
12. Khudyakov, Y. E., E. N. Lopareva, D. L. Jue, T. K. Crews, S. P. Thyagarajan, and H. A. Fields. 1999. Antigenic domains of the open reading frame 2-encoded protein of hepatitis E virus. J. Clin. Microbiol. 37:2863-2871.
13. Lam, W. Y., R. C. Chan, J. J. Sung, and P. K. Chan. 2009. Genotype distribution and sequence variation of hepatitis E virus, Hong Kong. Emerg. Infect. Dis. 15:792-794.
14. Legrand-Abravanel, F., J. M. Mansuy, M. Dubois, N. Kamar, J. M. Peron, L. Rostaing, and J. Izopet. 2009. Hepatitis E virus genotype 3 diversity, France. Emerg. Infect. Dis. 15:110-114.
15. Li, S. W., J. Zhang, Z. Q. He, Y. Gu, R. S. Liu, J. Lin, Y. X. Chen, M. H. Ng, and N. S. Xia. 2005. Mutational analysis of essential interactions involved in the assembly of hepatitis E virus capsid. J. Biol. Chem. 280:3400-3406.
16. Meky, F. A., S. K. Stoszek, M. Abdel-Hamid, S. Selim, A. Abdel-Wahab, N. Mikhail, S. El-Kafrawy, M. El-Daly, F. Abdel-Aziz, S. Sharaf, M. K. Mohamed, R. E. Engle, S. U. Emerson, R. H. Purcell, A. D. Fix, and G. T. Strickland. 2006. Active surveillance for acute viral hepatitis in rural villages in the Nile Delta. Clin. Infect. Dis. 42:628-633.
17. Meng, J., X. Dai, J. C. Chang, E. Lopareva, J. Pillot, H. A. Fields, and Y. E. Khudyakov. 2001. Identification and characterization of the neutralization epitope(s) of the hepatitis E virus. Virology 288:203-211.
18. Myint, K. S., M. Guan, H. Y. Chen, Y. Lu, D. Anderson, T. Howard, H. Noedl, and M. P. Mammen. 2005. Evaluation of a new rapid immunochromatographic assay for serodiagnosis of acute hepatitis E infection. Am. J. Trop. Med. Hyg. 73:942-946.
19. Purcell, R. H., and S. U. Emerson. 2008. Hepatitis E: an emerging awareness of an old disease. J. Hepatol. 48:494-503.
20. Schofield, D. J., R. H. Purcell, H. T. Nguyen, and S. U. Emerson. 2003. Monoclonal antibodies that neutralize HEV recognize an antigenic site at the carboxy terminus of an ORF2 protein vaccine. Vaccine 22:257-267.
21. Seriwatana, J., M. P. Shrestha, R. M. Scott, S. A. Tsarev, D. W. Vaughn, K. S. Myint, and B. L. Innis. 2002. Clinical and epidemiological relevance of quantitating hepatitis E virus-specific immunoglobulin M. Clin. Diagn. Lab. Immunol. 9:1072-1078.
22. Takahashi, M., T. Nishizawa, A. Yoshikawa, S. Sato, N. Isoda, K. Ido, K. Sugano, and H. Okamoto. 2002. Identification of two distinct genotypes of hepatitis E virus in a Japanese patient with acute hepatitis who had not travelled abroad. J. Gen. Virol. 83:1931-1940.
23. Tyagi, S., S. Jameel, and S. K. Lal. 2001. The full-length and N-terminal deletion of ORF2 protein of hepatitis E virus can dimerize. Biochem. Biophys. Res. Commun. 286:214-221.
24. Wang, Y., R. Ling, J. C. Erker, H. Zhang, H. Li, S. Desai, I. K. Mushahwar, and T. J. Harrison. 1999. A divergent genotype of hepatitis E virus in Chinese patients with acute hepatitis. J. Gen. Virol. 80:169-177.
25. Wang, Y., H. Zhang, R. Ling, H. Li, and T. J. Harrison. 2000. The complete sequence of hepatitis E virus genotype 4 reveals an alternative strategy for translation of open reading frames 2 and 3. J. Gen. Virol. 81:1675-1686.
26. Worm, H. C., W. H. van der Poel, and G. Brandstatter. 2002. Hepatitis E: an overview. Microbes Infect. 4:657-666.
27. Xiaofang, L., M. Zafrullah, F. Ahmad, and S. Jameel. 2001. A C-terminal hydrophobic region is required for homo-oligomerization of the hepatitis E virus capsid (ORF2) protein. J. Biomed. Biotechnol. 1:122-128.
28. Zhang, J., S. X. Ge, G. Y. Huang, S. W. Li, Z. Q. He, Y. B. Wang, Y. J. Zheng, Y. Gu, M. H. Ng, and N. S. Xia. 2003. Evaluation of antibody-based and nucleic acid-based assays for diagnosis of hepatitis E virus infection in a rhesus monkey model. J. Med. Virol. 71:518-526.
29. Zhou, Y. H., R. H. Purcell, and S. U. Emerson. 2004. An ELISA for putative neutralizing antibodies to hepatitis E virus detects antibodies to genotypes 1, 2, 3, and 4. Vaccine 22:2578-2585.
30. Zhou, Y. H., R. H. Purcell, and S. U. Emerson. 2005. A truncated ORF2 protein contains the most immunogenic site on ORF2: antibody responses to nonvaccine sequences following challenge of vaccinated and non-vaccinated macaques with hepatitis E virus. Vaccine 23:3157-3165.